| Issue Date | Title | Author(s) |
| 2020-10-30 | Antiproliferative effects of boswellic acids-loaded chitosan nanoparticles on human lung cancer cell line A549. | Solanki, N; Mehta, M; Chellappan, DK; Gupta, G; Hansbro, NG; Tambuwala, MM; Aa Aljabali, A; Paudel, KR; Liu, G; Satija, S; Hansbro, PM; Dua, K; Dureja, H |
| 2020-02-04 | Monotherapy of RAAS blockers and mobilization of aldosterone: A mechanistic perspective study in kidney disease. | Gupta, G; Dahiya, R; Singh, Y; Mishra, A; Verma, A; Gothwal, SK; Aljabali, AAA; Dureja, H; Prasher, P; Negi, P; Kapoor, DN; Goyal, R; Tambuwala, MM; Chellappan, DK; Dua, K |
| 2020-01 | COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development. | Aljabali, AAA; Bakshi, HA; Satija, S; Meenu,; Prasher, P; Ennab, RM; Chellappan, DK; Gupta, G; Negi, P; Goyal, R; Sharma, A; Mishra, V; Dureja, H; Dua, K; Tambuwala, MM |
| 2021-02-04 | Activation of TWEAK/Fn14 signaling suppresses TRAFs/NF-κB pathway in the pathogenesis of cancer | Gupta, G; Kazmi, I; Al-Abbasi, FA; Singh, Y; S, R; Rani, S; Mishra, A; Prasher, P; Jha, NK; Thangavelu, L; Dureja, H; Singh, SK; Bhatt, S; Chellappan, DK; Dua, K |
| 2021-07 | Middle East Respiratory Syndrome (MERS) Virus—Pathophysiological Axis and the Current Treatment Strategies | Alnuqaydan, AM; Almutary, AG; Sukamaran, A; Yang, BTW; Lee, XT; Lim, WX; Ng, YM; Ibrahim, R; Darmarajan, T; Nanjappan, S; Chellian, J; Candasamy, M; Madheswaran, T; Sharma, A; Dureja, H; Prasher, P; Verma, N; Kumar, D; Palaniveloo, K; Bisht, D; Gupta, G; Madan, JR; Singh, SK; Jha, NK; Dua, K; Chellappan, DK |
| - | Effects of curcumin-loaded poly(lactic-co-glycolic acid) nanoparticles in MDA-MB231 human breast cancer cells | Sharma, A; Hawthorne, S; Jha, SK; Jha, NK; Kumar, D; Girgis, S; Goswami, VK; Gupta, G; Singh, S; Dureja, H; Chellappan, DK; Dua, K |
| - | Advances in pulmonary drug delivery targeting microbial biofilms in respiratory diseases | Sharma, A; Kumar, D; Dahiya, K; Hawthorne, S; Jha, SK; Jha, NK; Nand, P; Girgis, S; Raj, S; Srivastava, R; Goswami, VK; Gregoriou, Y; El-Zahaby, SA; Ojha, S; Dureja, H; Gupta, G; Singh, S; Chellappan, DK; Dua, K |
| - | Emerging cases of mucormycosis under COVID ‐19 pandemic in India: Misuse of antibiotics | Gupta, G; S., R; Singh, Y; Thangavelu, L; Singh, SK; Dureja, H; Chellappan, DK; Dua, K |
| - | Emerging cases of mucormycosis under COVID ‐19 pandemic in India: Misuse of antibiotics | Gupta, G; S., R; Singh, Y; Thangavelu, L; Singh, SK; Dureja, H; Chellappan, DK; Dua, K |
| 2021-02-24 | An overview of vaccine development for COVID-19 | Shahcheraghi, SH; Ayatollahi, J; Aljabali, AA; Shastri, MD; Shukla, SD; Chellappan, DK; Jha, NK; Anand, K; Katari, NK; Mehta, M; Satija, S; Dureja, H; Mishra, V; Almutary, AG; Alnuqaydan, AM; Charbe, N; Prasher, P; Gupta, G; Dua, K; Lotfi, M; Bakshi, HA; Tambuwala, MM |
